Correlation Between Equillium and Nuvectis Pharma

Can any of the company-specific risk be diversified away by investing in both Equillium and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Nuvectis Pharma, you can compare the effects of market volatilities on Equillium and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Nuvectis Pharma.

Diversification Opportunities for Equillium and Nuvectis Pharma

0.55

Correlation Coefficient

Equillium  Nuvectis Pharma

Very weak diversification

The 3 months correlation between Equillium and Nuvectis is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Equillium i.e., Equillium and Nuvectis Pharma go up and down completely randomly.

Pair Corralation between Equillium and Nuvectis Pharma

Allowing for the 90-day total investment horizon Equillium is expected to generate 3.35 times less return on investment than Nuvectis Pharma. But when comparing it to its historical volatility, Equillium is 1.22 times less risky than Nuvectis Pharma. It trades about 0.08 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  452.00  in Nuvectis Pharma on October 21, 2024 and sell it today you would earn a total of  97.00  from holding Nuvectis Pharma or generate 21.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Nuvectis Pharma

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Nuvectis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Equillium and Nuvectis Pharma

The main advantage of trading using opposite Equillium and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.

The idea behind Equillium and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.